Emcure Pharmaceuticals has acquired the remaining 12.05% stake in Gennova Biopharmaceuticals, making the Maharashtra based biotechnology company a wholly owned subsidiary. The move is aimed at strengthening Emcure's presence in the fast-growing biologics and biosimilars segment while simplifying the company's ownership structure under its One
